HPV detection in anal canal samples
ProcedureAdditional anal taking during the colonoscopy with cytobrush
NCT Number: NCT02862795
Human papillomavirus (HPV) are involved in up to 95 % of anal canal neoplastic lesions. Little is known about HPV carriage in anal canal previous to cancer occurrence in the population and pre-neoplastic lesions, and their risk factors. PAPILLAN is a prospective study that aims to study HPV infection (HPV low grade and high grade genotypes) prevalence in anal canal in a population non selected by its HIV status. In that purpose patients are prospectively recruited in a french university hospital gastroenterology unit and anal smears are collected during a colonoscopy with cytobrush.
Looking for future studies?
Notify Me18 year and older
All sexes
Interventional
Not applicable
Centre Hospitalier Régional Universitaire de Besançon, Besançon, France
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Additional anal taking during the colonoscopy with cytobrush
Time frame: at inclusion (the day of colonoscopy)
Centre Hospitalier Universitaire de Besancon
Other
Human PapillomaVirus (HPV) Anal Infection: Study of Prevalence and Risk Factors Among 1000 Patients Benefiting From a Colonoscopy
Acronym: PAPILLAN
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT06302725
Communicable Diseases, DNA Virus Infections
Paris, France
View Trial DetailsNCT06162676
Communicable Diseases, DNA Virus Infections
East Lansing, Michigan, United States
View Trial DetailsNCT06752083
Communicable Diseases, DNA Virus Infections
Varese, Italy
View Trial DetailsNCT05524025
Communicable Diseases, DNA Virus Infections
Boston, Massachusetts, United States
View Trial Details